Inside the Markets
U
UCB
Description
UCB is a Belgian multinational biopharmaceutical company focused on severe diseases in neurology and immunology.
Key risks
market-risk
This risk may negatively affect the instrument’s performance under certain market conditions.
sector-risk
This risk may negatively affect the instrument’s performance under certain market conditions.
The list of risks is not exhaustive and highlights the most material structural and market-related factors.
Portfolio role & behavior
Economic role
growth
Behavior
defensive
The information provided is for analytical and informational purposes only and does not constitute investment advice.
Any decisions are made independently by the user and at their own risk.
For details, see legal terms.